Aleksandr Ianevski

15PUBLICATIONS
126CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursPharmaceutical delivery technologiesModelling and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 19, 2026
Combined ATR and mitotic inhibition is effective against MYCN-amplified neuroblastoma.

|Apr 27, 2026
Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

|Jan 12, 2026
Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.

Erlend Ravlo, Aleksandr Ianevski, Waleria Wolska

|Nov 19, 2025
JAK inhibitors remove innate immune barriers facilitating viral propagation.

Erlend Ravlo, Aleksandr Ianevski, Marius Nårstad Skipperstøen

|Oct 30, 2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Aleksandr Ianevski, Kristen Nader, Julia Nguyen

|May 12, 2025
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia.

Yingjia Chen, Liye He, Aleksandr Ianevski

Pageof 3

Frequent Collaborators

9 joint publications

Tero Aittokallio

5 joint publications

Anil K Giri

4 joint publications

Krister Wennerberg

3 joint publications

Denis Kainov